Literature DB >> 30153474

New DQA1 allele specific antibody against epitope 2D (an exon 1 encoded amino acid). Considerations for alleles under the same P-group designation.

Danny Youngs1, Paul Warner1, Mary Gallagher1, Idoia Gimferrer2.   

Abstract

The majority of polymorphisms of the Human Leukocyte Antigen (HLA) proteins are clustered at the peptide binding domain (PBD), defined as the area coded by exon 2 and 3 for class I and exon 2 for class II. HLA alleles with the same amino acid (AA) sequence at the PBD are considered functionally equivalent and can be grouped under the same P-group designation. Here we present a case of a kidney recipient, typed as DQA1*01:04, 01:05 and DQB1*05:01P, 05:03, who developed antibodies against all DQ antigens on our Luminex Single Antigen (LSA) panel. Our LSA panel does not include DQA1*01:05 or 01:04, but both alleles belong to the DQA1*01:01P group and beads carrying DQA1*01:01 tested positive. Mature protein sequence alignment demonstrated a single AA mismatch between DQA1*01:04/01:05 and DQA1*01:01 located at position 2 (G vs D), which is encoded by exon 1. Luminex assay by another manufacturer which include a bead carrying patient's own DQA1* type and crossmatch studies with surrogate donors confirmed the presence of an antibody against mismatched epitope 2D. This case illustrates that alleles included in the same P-group may have polymorphisms able to trigger immunological responses and brings attention to the fact that some mature HLA proteins express AA encoded by exon 1, which is structurally part of the PBD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DSA; HLA; Nomenclature; P-group; Polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30153474     DOI: 10.1016/j.trim.2018.08.007

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  1 in total

1.  HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.

Authors:  Suzanne Bezstarosti; Cynthia S M Kramer; Marry E I Franke-van Dijk; Manon Vergunst; Kim H Bakker; Merve Uyar-Mercankaya; Rico Buchli; Dave L Roelen; Johan W de Fijter; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.